EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Rosuvastatin protects against oxLDL-induced endothelial cell oxidative stress and attenuates atherosclerotic plaque formation in ApoE-/- mice through the NF-κB pathway

Yichen Wu, Jiaqi Ke, Jiaxin Lv, Chaowei Cao, Chunxian Zhou, Lili Wu iD, Qiyang Zhou

PLOS One · 2026

DOI: 10.1371/journal.pone.0339967 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, 2026. Verfasst von Yichen Wu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Interventional Medicine Department, Suzhou Ninth Hospital Affiliated to Soochow University, Suzhou, Jiangsu, China. Hauptthemen laut MEDLINE: Rosuvastatin Calcium, Oxidative Stress, Lipoproteins, LDL, NF-kappa B. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Youth Science Foundation of Suzhou Ninth People’s Hospital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cardiovascular disease is one of the diseases with the highest global incidence and mortality rates, and atherosclerosis is its basic cause. Endothelial dysfunction induced by risk factors such as lipid oxidation or inflammatory stimulation is a critical stage in the development of atherosclerosis, with endothelial oxidative stress and apoptosis serving as important pathological bases. Rosuvastatin influences the occurrence of atherosclerosis by regulating lipid levels. In this study, we investigated the effects of rosuvastatin on ox-LDL-induced endothelial cell injury and atherosclerosis. The results showed that intragastric administration of rosuvastatin inhibited high-fat diet (HFD)-induced changes in the aortic plaque area and aortic root lipid deposition in mice. In addition, rosuvastatin reduced mouse body weight and decreased the plasma levels of low-density lipoprotein (LDL) and total cholesterol (TC). The in vitro results demonstrated that rosuvastatin suppressed ox-LDL-induced endothelial oxidative stress, promoted the expression of nitric oxide (NO) and endothelial nitric oxide synthase (eNOS), and reduced intracellular reactive oxygen species (ROS) production. Additionally, rosuvastatin protected against ox-LDL-induced endothelial apoptosis by increasing Bcl-2 expression and decreasing Bax expression. Mechanistically, rosuvastatin inhibited the activation of the NF-κB signaling pathway induced by ox-LDL and suppressed the phosphorylation of P65, thereby reducing the expression of molecules related to oxidative stress and apoptosis. In conclusion, this study suggests that rosuvastatin may attenuate atherosclerosis by inhibiting endothelial oxidative stress and apoptosis, which provides a theoretical basis for the prevention and treatment of atherosclerosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Rosuvastatin CalciumOxidative StressLipoproteins, LDLNF-kappa BPlaque, AtheroscleroticApolipoproteins EEndothelial CellsAnimalsMiceSignal TransductionMaleNitric Oxide Synthase Type IIIReactive Oxygen SpeciesNitric OxideApoptosisAtherosclerosisDiet, High-FatHumans

Substanzen

Rosuvastatin Calciumoxidized low density lipoproteinLipoproteins, LDLNF-kappa BApolipoproteins ENitric Oxide Synthase Type IIIReactive Oxygen SpeciesNitric Oxide

Autor:innen und Institutionen

  • Interventional Medicine Department, Suzhou Ninth Hospital Affiliated to Soochow University, Suzhou, Jiangsu, China.
  • Cyrus Tang Medical Institute, Soochow University, Suzhou, Jiangsu, China.

ORCID-Profile: Lili Wu

Förderung

  • Youth Science Foundation of Suzhou Ninth People’s Hospital

Zitieren

APA

Wu, Y., Ke, J., Lv, J., Cao, C., Zhou, C., Wu, L., & Zhou, Q. (2026). Rosuvastatin protects against oxLDL-induced endothelial cell oxidative stress and attenuates atherosclerotic plaque formation in ApoE-/- mice through the NF-κB pathway. PLOS One. https://doi.org/10.1371/journal.pone.0339967

Vancouver

Wu Y, Ke J, Lv J, Cao C, Zhou C, Wu L, et al. Rosuvastatin protects against oxLDL-induced endothelial cell oxidative stress and attenuates atherosclerotic plaque formation in ApoE-/- mice through the NF-κB pathway. PLOS One. 2026. doi:10.1371/journal.pone.0339967

BibTeX
@article{Wu2026,
  author = {Wu, Yichen and Ke, Jiaqi and Lv, Jiaxin and Cao, Chaowei and Zhou, Chunxian and Wu, Lili and Zhou, Qiyang},
  title = {Rosuvastatin protects against oxLDL-induced endothelial cell oxidative stress and attenuates atherosclerotic plaque formation in ApoE-/- mice through the NF-κB pathway},
  journal = {PLOS One},
  year = {2026},
  doi = {10.1371/journal.pone.0339967}
}
Kostenlos starten →